Asking hospitalized older adults about CPR and code status through the electronic medical record using different wording
Official title: Choice of Diction's Effect: Electronic Measures of Resuscitation Status Inpatient
Run by Rutgers, The State University of New Jersey · NCT07405710 · Data updated 2026-11-12
This trial tests whether different ways of wording CPR and 'death' in the hospital electronic patient portal change how adults 65 and older choose their code status.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 65 Years and up |
| Sex | All |
| Enrollment | 118 (estimated) |
| Sponsor | Rutgers, The State University of New Jersey Academic / other |
| Locations | 1 site (New Brunswick, New Jersey) |
| Status | Recruiting |
| Started | February 9, 2026 |
| Main results expected | June 30, 2027 |
| Study ends | June 30, 2027 |
| Registry record updated | February 12, 2026 |
| Trial ID | NCT07405710 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Hospitalized, English-speaking adults age >65 who have capacity to consent and are not in the ICU are the ideal participants.
✕Probably not a fit
Patients who are critically ill in the ICU, who cannot consent, or who are not English-fluent are unlikely to benefit from this enrollment pathway.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Hospitalized patients over age 65 who can consent and read English are invited to complete electronic questionnaires delivered via the medical record/portal. Participants are shown alternate phrasings of code status prompts, some including explicit 'death' language, and their choices (full code versus no resuscitation) are recorded; prior portal use is tracked to see if it affects participation. Physicians also review objective risk scores (for example GO-FAR and Charlson Comorbidity Index) to measure agreement with patient-selected code status. Data collection is electronic but participants may request to speak with a study physician, and patients requiring ICU-level care are excluded.
Why it matters
Potential benefit: If successful, this approach could make conversations and documentation about CPR preferences clearer and increase alignment between patient wishes and medical records.
How similar studies have gone: Previous work has shown that wording can change advance care choices, but applying explicit 'death' language via the EMR portal for inpatients is a relatively new approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \>65, English-fluency in reading and speaking, and the capacity to consent Exclusion Criteria: * Requiring ICU-level care
Where it's running
-
Robert Wood Johnson University Hospital - New Brunswick
New Brunswick, New Jersey, United States Recruiting
Study contacts
- Principal investigator: Karthik J Kota, MD MPH — Assistant Professor of Medicine
- Study coordinator: Karthik J Kota, MD MPH
- Email: karthik.kota@rutgers.edu
- Phone: 732-235-7112
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ctDNA-guided stopping of immune therapy in advanced melanoma
This study tests whether stopping immune checkpoint inhibitor therapy after 12 months is safe for patients with advanced melanoma who have undetectable ctDNA and disease control.
-
Personalized brain-targeted TMS for smoking cessation
A personalized brain-guided Transcranial Magnetic Stimulation (TMS) approach is tested against a standard TMS method to see if it better changes reward brain activity and reduces cravings and smoking in adults with tobacco use disorder.
-
Luminal Bladder Cancer: Testing Neoadjuvant Therapy vs Immediate Surgery in Luminal MIBC
We’re testing whether moving straight to radical cystectomy is safe and effective for patients with luminal muscle-invasive bladder cancer compared to the standard neoadjuvant therapy followed by surgery.
-
Genetics of Blood Cancers in the U.S. population
This study tests how genetic factors relate to blood cancers by collecting saliva DNA and online health surveys from at least 10,000 U.S. adults.
-
Sun Safe Together: a digital skin cancer prevention approach for teens and their parents
A small, single-arm trial will test whether a 12-week digital program using teen MMS messages and a private Facebook group for parents can feasibly and acceptably improve sun safety among adolescents and their parents.
-
Exercise and nasal insulin in Type 2 diabetes: does adding insulin spray help the brain more
In older adults with Type 2 diabetes, researchers are testing whether combining regular exercise with an intranasal insulin spray improves brain blood flow and thinking abilities more than exercise with a placebo spray.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.